Jain Foundation Inc
501C3 Nonprofit Organization Information
Jain Foundation Inc is a 501(c)(3) private foundation in Seattle, Washington (EIN 20-0284800). It has been tax-exempt since March 2006, and contributions to it are tax-deductible. Its Form 990-PF for tax year 2024 reports total revenue of $384,162 and net assets of $51,115,078, and it paid $3,436,865 in grants. TaxExemptWorld has Form 990s on file for 18 tax years (2006–2024). The IRS classifies its activity as Nerve, Muscle and Bone Diseases (NTEE G50). It is one of 13,270 nonprofits in Seattle, WA.
Form 990-PF · Tax period ending Dec 2024 · Filed Nov 3, 2025 · From the IRS e-file data
Dollar amounts for every revenue and expense line are in the full 990 report.
While the focus of the Jain Foundation is Dysferlinopathy (LGMD2B/R2/Miyoshi Myopathy1), the resulting scientific advances and collaborations that we make have a broader impact on human health through their relevance to other muscle disorders, degenerative diseases, and normal aging. The Foundation takes a hands-on approach to funding. We closely monitor the progress of every project we fund and keep track of results and shifting timelines through quarterly conference calls with researchers and site visits. We also support internal programs and initiatives. Our goal is to fund all possible ap…
Clinical Trial readiness and Community Engagement ($246,298): Dysferlinopathy is very rare. An important goal of the Jain Foundation is to prepare the dysferlinopathy patient community for clinical trials. There are many aspects to being clinical trial ready, including patient identification, community engagement, patient education, and identification of outcome measures. For patient identification we have a patient registry called the Dysferlin Registry that contains 1200+ individuals verified to have dysferlinopathy. In addition, we have a diagnosis pipeline that provides access to genetic …
Tools for Researchers ($257,622): As a recognized leader in the field, we continue to receive queries and help researchers access reagents such as antibodies and cell lines that are required for their research. In addition, we actively identify and fund the development of research tools and resources needed to advance the dysferlin field. The Jain Foundation is committed to developing and providing frequently required reagents, the availability of which helps accelerate research. We contributed dysferlin DNA to public repositories and have helped companies develop antibodies to dysferlin so t…
Prepared by TaxExemptWorld from IRS Form 990-PF e-file data (object ID 202533079349101423). Not an official IRS form.